Document Detail


Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study.
MedLine Citation:
PMID:  19913778     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: We sought to verify if an oral contraceptive (OC) containing drospirenone affects the cardiovascular risk of patients with polycystic ovary syndrome (PCOS). STUDY DESIGN: A total of 28 women with PCOS (16 lean [group A] and 12 overweight [group B]) were assessed at baseline and after 6 months therapy with an OC. Leptin, homocysteine, endothelin-1, and flow-mediated dilatation of brachial artery were measured. RESULTS: The brachial artery diameter and the pulsatility index, after the reactive hyperemia, did not change in group A; it improved significantly in group B after 6 months of treatment. At baseline and after therapy the plasma levels of homocysteine and endothelin-1 did not differ among the groups. Leptin was significantly lower at baseline in group A compared to group B. CONCLUSION: The OC containing drospirenone does not seem to affect the surrogate markers of cardiovascular risk in lean patients with PCOS.
Authors:
Fulvia Mancini; Arianna Cianciosi; Nicola Persico; Fabio Facchinetti; Paolo Busacchi; Cesare Battaglia
Related Documents :
16690058 - Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic c...
649288 - Choriogonin treatment of patients with pathospermia.
22882208 - Facial skin barrier function recovery after microneedle transdermal delivery treatment.
22589018 - Reduction of skin closure time without loss of healing quality: a multicenter prospecti...
20572828 - Correcting post-keratoplasty anisometropia with the implantable collamer phakic intraoc...
3318428 - Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin.
Publication Detail:
Type:  Journal Article     Date:  2009-11-14
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  202     ISSN:  1097-6868     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-01     Completed Date:  2010-02-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  169.e1-8     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 Mosby, Inc. All rights reserved.
Affiliation:
Department of Obstetrics and Gynecology, University of Bologna, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aldosterone Antagonists / pharmacology*
Androstenes / pharmacology*
Brachial Artery / physiopathology
Cardiovascular Diseases / etiology*
Contraceptives, Oral / pharmacology
Endothelin-1 / blood
Female
Homocysteine / blood
Humans
Insulin / blood
Insulin Resistance
Leptin / blood
Obesity / complications*
Pilot Projects
Polycystic Ovary Syndrome / complications*
Chemical
Reg. No./Substance:
0/Aldosterone Antagonists; 0/Androstenes; 0/Contraceptives, Oral; 0/Endothelin-1; 0/Leptin; 11061-68-0/Insulin; 454-28-4/Homocysteine; 67392-87-4/drospirenone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors governing partial coalescence in oil-in-water emulsions.
Next Document:  Effect of Intrathecal Baclofen Bolus Injection on Lower Extremity Joint Range of Motion During Gait ...